These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35697134)

  • 41. A Curated Database of Rodent Uterotrophic Bioactivity.
    Kleinstreuer NC; Ceger PC; Allen DG; Strickland J; Chang X; Hamm JT; Casey WM
    Environ Health Perspect; 2016 May; 124(5):556-62. PubMed ID: 26431337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 17α-Ethinylestradiol (EE2) effect on global gene expression in primary rainbow trout (Oncorhynchus mykiss) hepatocytes.
    Hultman MT; Song Y; Tollefsen KE
    Aquat Toxicol; 2015 Dec; 169():90-104. PubMed ID: 26519835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of Androgen Receptor Modulators in a Prostate Cancer Cell Line Microarray Compendium.
    Rooney JP; Chorley B; Kleinstreuer N; Corton JC
    Toxicol Sci; 2018 Nov; 166(1):146-162. PubMed ID: 30085300
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endocrine profiling and prioritization of environmental chemicals using ToxCast data.
    Reif DM; Martin MT; Tan SW; Houck KA; Judson RS; Richard AM; Knudsen TB; Dix DJ; Kavlock RJ
    Environ Health Perspect; 2010 Dec; 118(12):1714-20. PubMed ID: 20826373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of EPA's Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening results.
    Borgert CJ; Mihaich EM; Quill TF; Marty MS; Levine SL; Becker RA
    Regul Toxicol Pharmacol; 2011 Apr; 59(3):397-411. PubMed ID: 21251942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of the interaction of phytoestrogens and synthetic chemicals: an in vitro/in vivo comparison.
    Charles GD; Gennings C; Tornesi B; Kan HL; Zacharewski TR; Bhaskar Gollapudi B; Carney EW
    Toxicol Appl Pharmacol; 2007 Feb; 218(3):280-8. PubMed ID: 17222880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
    Lazennec G; Katzenellenbogen BS
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):93-105. PubMed ID: 10375022
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use and acceptance of Other Scientifically Relevant Information (OSRI) in the U.S. Environmental Protection Agency (EPA) Endocrine Disruptor Screening Program.
    Bishop PL; Willett CE
    Birth Defects Res B Dev Reprod Toxicol; 2014 Feb; 101(1):3-22. PubMed ID: 24151143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identifying reference chemicals for thyroid bioactivity screening.
    Wegner S; Browne P; Dix D
    Reprod Toxicol; 2016 Oct; 65():402-413. PubMed ID: 27589887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toxicity testing and endocrine disrupting chemicals.
    Vandenberg LN
    Adv Pharmacol; 2021; 92():35-71. PubMed ID: 34452691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A transcriptomic biomarker predictive of cell proliferation for use in adverse outcome pathway-informed testing and assessment.
    Corton JC; Ledbetter V; Cohen SM; Atlas E; Yauk CL; Liu J
    Toxicol Sci; 2024 Oct; 201(2):174-189. PubMed ID: 39137154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective activation of zebrafish estrogen receptor subtypes by chemicals by using stable reporter gene assay developed in a zebrafish liver cell line.
    Cosnefroy A; Brion F; Maillot-Maréchal E; Porcher JM; Pakdel F; Balaguer P; Aït-Aïssa S
    Toxicol Sci; 2012 Feb; 125(2):439-49. PubMed ID: 22045033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development, validation and integration of in silico models to identify androgen active chemicals.
    Manganelli S; Roncaglioni A; Mansouri K; Judson RS; Benfenati E; Manganaro A; Ruiz P
    Chemosphere; 2019 Apr; 220():204-215. PubMed ID: 30584954
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular characterization of estrogen receptor genes in Gobiocypris rarus and their expression upon endocrine disrupting chemicals exposure in juveniles.
    Wang H; Wang J; Wu T; Qin F; Hu X; Wang L; Wang Z
    Aquat Toxicol; 2011 Jan; 101(1):276-87. PubMed ID: 21111493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of the Key Characteristics Framework to Identify Potential Breast Carcinogens Using Publicly Available
    Kay JE; Brody JG; Schwarzman M; Rudel RA
    Environ Health Perspect; 2024 Jan; 132(1):17002. PubMed ID: 38197648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
    Tian X; Zhang Z
    IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells.
    Wang C; Mayer JA; Mazumdar A; Brown PH
    Breast Cancer Res Treat; 2012 Jun; 133(2):487-500. PubMed ID: 21947652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endocrine Disruptors: Data-based survey of in vivo tests, predictive models and the Adverse Outcome Pathway.
    Benigni R; Battistelli CL; Bossa C; Giuliani A; Tcheremenskaia O
    Regul Toxicol Pharmacol; 2017 Jun; 86():18-24. PubMed ID: 28232102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Robust array-based coregulator binding assay predicting ERα-agonist potency and generating binding profiles reflecting ligand structure.
    Aarts JM; Wang S; Houtman R; van Beuningen RM; Westerink WM; Van De Waart BJ; Rietjens IM; Bovee TF
    Chem Res Toxicol; 2013 Mar; 26(3):336-46. PubMed ID: 23383871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
    Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
    Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.